Correlation Between Veracyte and NLS Pharmaceutics
Can any of the company-specific risk be diversified away by investing in both Veracyte and NLS Pharmaceutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Veracyte and NLS Pharmaceutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Veracyte and NLS Pharmaceutics AG, you can compare the effects of market volatilities on Veracyte and NLS Pharmaceutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Veracyte with a short position of NLS Pharmaceutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Veracyte and NLS Pharmaceutics.
Diversification Opportunities for Veracyte and NLS Pharmaceutics
-0.73 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Veracyte and NLS is -0.73. Overlapping area represents the amount of risk that can be diversified away by holding Veracyte and NLS Pharmaceutics AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NLS Pharmaceutics and Veracyte is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Veracyte are associated (or correlated) with NLS Pharmaceutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NLS Pharmaceutics has no effect on the direction of Veracyte i.e., Veracyte and NLS Pharmaceutics go up and down completely randomly.
Pair Corralation between Veracyte and NLS Pharmaceutics
Given the investment horizon of 90 days Veracyte is expected to generate 0.44 times more return on investment than NLS Pharmaceutics. However, Veracyte is 2.25 times less risky than NLS Pharmaceutics. It trades about 0.39 of its potential returns per unit of risk. NLS Pharmaceutics AG is currently generating about -0.02 per unit of risk. If you would invest 3,374 in Veracyte on September 1, 2024 and sell it today you would earn a total of 921.00 from holding Veracyte or generate 27.3% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Veracyte vs. NLS Pharmaceutics AG
Performance |
| Timeline |
| Veracyte |
| NLS Pharmaceutics |
Veracyte and NLS Pharmaceutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Veracyte and NLS Pharmaceutics
The main advantage of trading using opposite Veracyte and NLS Pharmaceutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Veracyte position performs unexpectedly, NLS Pharmaceutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NLS Pharmaceutics will offset losses from the drop in NLS Pharmaceutics' long position.| Veracyte vs. Crinetics Pharmaceuticals | Veracyte vs. Viridian Therapeutics | Veracyte vs. Cytokinetics | Veracyte vs. Structure Therapeutics American |
| NLS Pharmaceutics vs. Neurobo Pharmaceuticals | NLS Pharmaceutics vs. Indaptus Therapeutics | NLS Pharmaceutics vs. Pasithea Therapeutics Corp | NLS Pharmaceutics vs. Quoin Pharmaceuticals Ltd |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.
Other Complementary Tools
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |